Skip to Content

ICON Equity Income Investor IEQAX

Medalist Rating as of | See ICON Investment Hub
  • NAV / 1-Day Return 15.40  /  −0.71 %
  • Total Assets 47.5 Mil
  • Adj. Expense Ratio
    1.430%
  • Expense Ratio 1.430%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Aggressive Allocation
  • Investment Style Mid Value
  • Credit Quality / Interest Rate Sensitivity
  • Status Closed
  • TTM Yield 4.50%
  • Turnover 43%

USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 10:14 PM GMT+0

Morningstar’s Analysis IEQAX

Will IEQAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in ICON Equity Income Investor's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IEQAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 43.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

GSK PLC ADR

5.63 2.8 Mil
Healthcare

Amgen Inc

5.54 2.7 Mil
Healthcare

Vector Group Ltd

5.41 2.7 Mil
Consumer Defensive

ING Groep NV ADR

4.82 2.4 Mil
Financial Services

DTE Energy Co

4.25 2.1 Mil
Utilities

Nexstar Media Group Inc

4.12 2.0 Mil
Communication Services

Lockheed Martin Corp

4.06 2.0 Mil
Industrials

Ingredion Inc

3.48 1.7 Mil
Consumer Defensive

KeyCorp

3.45 1.7 Mil
Financial Services

Bristol-Myers Squibb Co

3.13 1.5 Mil
Healthcare